<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33519765</PMID><DateRevised><Year>2021</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Frontiers in microbiology</Title><ISOAbbreviation>Front Microbiol</ISOAbbreviation></Journal><ArticleTitle>Novel Naturally Occurring Mutations of Enterovirus 71 Associated With Disease Severity.</ArticleTitle><Pagination><StartPage>610568</StartPage><MedlinePgn>610568</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">610568</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2020.610568</ELocationID><Abstract><AbstractText>Infection with the re-emerging enterovirus 71 (EV-A71) is associated with a wide range of disease severity, including herpangina, encephalitis, and cardiopulmonary failure. At present, there is no FDA-approved therapeutics for EV-A71. Early diagnosis for the high-risk children is the key to successful patient care. We examined viral genome sequences at the 5' untranslated region (UTR) and the capsid protein VP1 from 36 mild and 27 severe cases. We identified five EV-A71 mutations associated with severe diseases, including (1) the 5' UTR mutations C580U, A707G, C709U; (2) a VP1 alanine-to-threonine mutation at position 280 (280T), and (3) a VP1 glutamic acid-to-(non-glutamic acid) at position 145 [145(non-E)]. SCARB2 is a known entry receptor for EV-A71. Based on a recent cryoEM structure of the EV-A71-SCARB2 binding complex, VP1-280T is near the binding interface between the VP1-VP2 complex and its entry receptor SCARB2. A <i>de novo</i> created hydrogen bonding between the mutant VP1-280T and the VP2-139T, could help strengthen a web-like interaction structure of the VP1-VP2 complex. A stabilized loop turn of VP2, once in contact with SCARB2, can enhance interaction with the host SCARB2 receptor for viral entry. Our findings here could facilitate early detection of severe cases infected with EV-A71 in clinical medicine. In addition, it opens up the opportunity of functional studies via infectious cDNA cloning, site-directed mutagenesis, and animal models in the future.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Chang, Liao, Liou, Chou, Yu, Lin, Lin, Suen, Hwang and Shih.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chih-Shin</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Genomics Research Center, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Chun-Che</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liou</LastName><ForeName>An-Ting</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chou</LastName><ForeName>Yi-Chun</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Ya-Yen</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>Section of Clinical Virology and Molecular Diagnosis, Department of Laboratory Medicine, Changhua Christian Hospital, Changhua, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chi-Yung</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Section of Clinical Virology and Molecular Diagnosis, Department of Laboratory Medicine, Changhua Christian Hospital, Changhua, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jen-Shiou</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Section of Clinical Virology and Molecular Diagnosis, Department of Laboratory Medicine, Changhua Christian Hospital, Changhua, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suen</LastName><ForeName>Ching-Shu</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>Ming-Jing</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shih</LastName><ForeName>Chiaho</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Microbiol</MedlineTA><NlmUniqueID>101548977</NlmUniqueID><ISSNLinking>1664-302X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EV-A71</Keyword><Keyword MajorTopicYN="N">PSGL-1</Keyword><Keyword MajorTopicYN="N">SCARB2</Keyword><Keyword MajorTopicYN="N">VP1</Keyword><Keyword MajorTopicYN="N">VP2</Keyword><Keyword MajorTopicYN="N">disease severity</Keyword><Keyword MajorTopicYN="N">enterovirus 71</Keyword><Keyword MajorTopicYN="N">mutations</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>1</Day><Hour>5</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33519765</ArticleId><ArticleId IdType="pmc">PMC7838335</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2020.610568</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bible J. M., Iturriza-Gomara M., Megson B., Brown D., Pantelidis P., Earl P., et al. (2008). Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006. J. Clin. Microbiol. 46 3192&#x2013;3200. 10.1128/jcm.00628-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.00628-08</ArticleId><ArticleId IdType="pmc">PMC2566106</ArticleId><ArticleId IdType="pubmed">18650362</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C. K., Wu S. R., Chen Y. C., Lee K. J., Chung N. H., Lu Y. J., et al. (2018). Mutations in VP1 and 5&#x2019;-UTR affect enterovirus 71 virulence. Sci. Rep. 8:6688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5923339</ArticleId><ArticleId IdType="pubmed">29703921</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.-S., Liao C.-C., Liou A.-T., Chang Y.-S., Chang Y.-T., Tzeng B.-H., et al. (2019). Enterovirus 71 targets the cardiopulmonary system in a robust oral infection mouse model. Sci. Rep. 9:11108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6668393</ArticleId><ArticleId IdType="pubmed">31366973</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang G. H., Lin L., Luo Y. J., Cai L. J., Wu X. Y., Xu H. M., et al. (2010). Sequence analysis of six enterovirus 71 strains with different virulences in humans. Virus Res. 151 66&#x2013;73. 10.1016/j.virusres.2010.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2010.04.001</ArticleId><ArticleId IdType="pubmed">20398708</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang S. C., Li W. C., Chen G. W., Tsao K. C., Huang C. G., Huang Y. C., et al. (2012). Genetic characterization of enterovirus 71 isolated from patients with severe disease by comparative analysis of complete genomes. J. Med. Virol. 84 931&#x2013;939. 10.1002/jmv.23287</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23287</ArticleId><ArticleId IdType="pubmed">22499017</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P., Song Z., Qi Y., Feng X., Xu N., Sun Y., et al. (2012). Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. J. Biol. Chem. 287 6406&#x2013;6420. 10.1074/jbc.m111.301622</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.m111.301622</ArticleId><ArticleId IdType="pmc">PMC3307280</ArticleId><ArticleId IdType="pubmed">22219187</ArticleId></ArticleIdList></Reference><Reference><Citation>Choijilsuren G., Jhou R. S., Chou S. F., Chang C. J., Yang H. I., Chen Y. Y., et al. (2017). Heparin at physiological concentration can enhance PEG-free in vitro infection with human hepatitis B virus. Sci. Rep. 7:14461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5663848</ArticleId><ArticleId IdType="pubmed">29089529</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua B. H., Phuektes P., Sanders S. A., Nicholls P. K., McMinn P. C. (2008). The molecular basis of mouse adaptation by human enterovirus 71. J. Gen. Virol. 89 1622&#x2013;1632. 10.1099/vir.0.83676-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.83676-0</ArticleId><ArticleId IdType="pubmed">18559932</ArticleId></ArticleIdList></Reference><Reference><Citation>Connell B. J., Lortat-Jacob H. (2013). Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibition. Front. Immunol. 4:385. 10.3389/fimmu.2013.00385</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2013.00385</ArticleId><ArticleId IdType="pmc">PMC3834540</ArticleId><ArticleId IdType="pubmed">24312095</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordey S., Petty T. J., Schibler M., Martinez Y., Gerlach D., van Belle S., et al. (2012). Identification of site-specific adaptations conferring increased neural cell tropism during human enterovirus 71 infection. PLoS Pathogens 8:e1002826. 10.1371/journal.ppat.1002826</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002826</ArticleId><ArticleId IdType="pmc">PMC3406088</ArticleId><ArticleId IdType="pubmed">22910880</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox J. A., Hiscox J. A., Solomon T., Ooi M. H., Ng L. F. P. (2017). Immunopathogenesis and Virus-Host interactions of enterovirus 71 in patients with hand. foot and mouth disease. Front. Microbiol. 8:2249. 10.3389/fmicb.2017.02249</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.02249</ArticleId><ArticleId IdType="pmc">PMC5713468</ArticleId><ArticleId IdType="pubmed">29238324</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang M., Wang X., Wang Q., Wang Y., Lin J., Sun Y., et al. (2014). Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71. Protein Cell 5 692&#x2013;703. 10.1007/s13238-014-0087-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-014-0087-3</ArticleId><ArticleId IdType="pmc">PMC4145081</ArticleId><ArticleId IdType="pubmed">24986489</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Z., Hensley L., McKnight K. L., Hu F., Madden V., Ping L., et al. (2013). A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature 496 367&#x2013;371. 10.1038/nature12029</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12029</ArticleId><ArticleId IdType="pmc">PMC3631468</ArticleId><ArticleId IdType="pubmed">23542590</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii K., Sudaka Y., Takashino A., Kobayashi K., Kataoka C., Suzuki T., et al. (2018). VP1 Amino acid residue 145 of enterovirus 71 Is a Key residue for its receptor attachment and resistance to neutralizing antibody during cynomolgus monkey infection. J. Virol. 92:e00682-18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6052295</ArticleId><ArticleId IdType="pubmed">29848582</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M., Chen E. R., Hsu K. H., Twu S. J., Chen K. T., Tsai S. F., et al. (1999). An epidemic of enterovirus 71 infection in Taiwan. Taiwan enterovirus epidemic working group. New England J. Med. 341 929&#x2013;935. 10.1056/nejm199909233411301</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejm199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S. W., Wang Y. F., Yu C. K., Su I. J., Wang J. R. (2012). Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement. Virology 422 132&#x2013;143. 10.1016/j.virol.2011.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2011.10.015</ArticleId><ArticleId IdType="pubmed">22078110</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y. P., Lin T. L., Lin T. H., Wu H. S. (2013). Antigenic and genetic diversity of human enterovirus 71 from 2009 to 2012. Taiwan. PLoS One 8:e80942. 10.1371/journal.pone.0080942</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0080942</ArticleId><ArticleId IdType="pmc">PMC3858369</ArticleId><ArticleId IdType="pubmed">24348916</ArticleId></ArticleIdList></Reference><Reference><Citation>Kataoka C., Suzuki T., Kotani O., Iwata-Yoshikawa N., Nagata N., Ami Y., et al. (2015). The role of VP1 amino acid residue 145 of enterovirus 71 in viral fitness and pathogenesis in a cynomolgus monkey model. PLoS Pathog. 11:e1005033. 10.1371/journal.ppat.1005033</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005033</ArticleId><ArticleId IdType="pmc">PMC4504482</ArticleId><ArticleId IdType="pubmed">26181772</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K., Mizuta K., Koike S. (2020). Heparan sulfate attachment receptor is a major selection factor for attenuated enterovirus 71 mutants during cell culture adaptation. PLoS Pathog. 16:e1008428 10.1371/journal.ppat.1008428</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008428</ArticleId><ArticleId IdType="pmc">PMC7105141</ArticleId><ArticleId IdType="pubmed">32187235</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K., Sudaka Y., Takashino A., Imura A., Fujii K., Koike S. (2018). Amino acid variation at VP1-145 of enterovirus 71 determines attachment receptor usage and neurovirulence in human scavenger receptor b2 transgenic mice. J. Virol. 92:e00681-18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6052303</ArticleId><ArticleId IdType="pubmed">29848584</ArticleId></ArticleIdList></Reference><Reference><Citation>Kung Y. H., Huang S. W., Kuo P. H., Kiang D., Ho M. S., Liu C. C., et al. (2010). Introduction of a strong temperature-sensitive phenotype into enterovirus 71 by altering an amino acid of virus 3D polymerase. Virology 396 1&#x2013;9. 10.1016/j.virol.2009.10.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2009.10.017</ArticleId><ArticleId IdType="pubmed">19906393</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K. M., Gong Y. N., Hsieh T. H., Woodman A., Dekker N. H., Cameron C. E., et al. (2018). Discovery of Enterovirus A71-like nonstructural genomes in recent circulating viruses of the Enterovirus A species. Emerg. Microbes Infect. 7:111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6013424</ArticleId><ArticleId IdType="pubmed">29930332</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M. S., Lin T. Y., Chiang P. S., Li W. C., Luo S. T., Tsao K. C., et al. (2010). An investigation of epidemic enterovirus 71 infection in Taiwan, 2008: clinical, virologic, and serologic features. Pediatr. Infect. Dis. J. 29 1030&#x2013;1034.</Citation><ArticleIdList><ArticleId IdType="pubmed">20543760</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Zou Q., Chen L., Zhang H., Wang Y. (2011). Molecular analysis of virulent determinants of enterovirus 71. PLoS One 6:e26237. 10.1371/journal.pone.0026237</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0026237</ArticleId><ArticleId IdType="pmc">PMC3198388</ArticleId><ArticleId IdType="pubmed">22039449</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao C. C., Liou A. T., Chang Y. S., Wu S. Y., Chang C. S., Lee C. K., et al. (2014). Immunodeficient mouse models with different disease profiles by in vivo infection with the same clinical isolate of enterovirus 71. J. Virol. 88 12485&#x2013;12499. 10.1128/jvi.00692-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00692-14</ArticleId><ArticleId IdType="pmc">PMC4248922</ArticleId><ArticleId IdType="pubmed">25142603</ArticleId></ArticleIdList></Reference><Reference><Citation>Liou A. T., Liao C. C., Chou S. F., Chang Y. S., Chang C. S., Shih C. (2019). Hypoxia and therapeutic treatment of EV-A71 with an immune modulator TLR7 agonist in a new immunocompetent mouse model. J. Biomed. Sci. 26:93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6849267</ArticleId><ArticleId IdType="pubmed">31711481</ArticleId></ArticleIdList></Reference><Reference><Citation>Liou A. T., Wu S. Y., Liao C. C., Chang Y. S., Chang C. S., Shih C. (2016). A new animal model containing human SCARB2 and lacking stat-1 is highly susceptible to EV71. Sci. Rep. 6:31151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4976353</ArticleId><ArticleId IdType="pubmed">27499235</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P., Lindsay K., Perera D., Chan H. M., Chan K. P., Cardosa M. J. (2001). Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia. Singapore, and Western Australia. J. Virol. 75 7732&#x2013;7738. 10.1128/jvi.75.16.7732-7738.2001</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.75.16.7732-7738.2001</ArticleId><ArticleId IdType="pmc">PMC115010</ArticleId><ArticleId IdType="pubmed">11462047</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P. C. (2002). An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26 91&#x2013;107. 10.1111/j.1574-6976.2002.tb00601.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2002.tb00601.x</ArticleId><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamura K., Nishimura Y., Abo M., Wakita T., Shimizu H. (2011). Adaptive mutations in the genomes of enterovirus 71 strains following infection of mouse cells expressing human P-selectin glycoprotein ligand-1. J. Gen. Virol. 92 287&#x2013;291. 10.1099/vir.0.022418-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.022418-0</ArticleId><ArticleId IdType="pmc">PMC3081077</ArticleId><ArticleId IdType="pubmed">20943886</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y., Lee H., Hafenstein S., Kataoka C., Wakita T., Bergelson J. M., et al. (2013). Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction. PLoS Pathogens 9:e1003511. 10.1371/journal.ppat.1003511</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003511</ArticleId><ArticleId IdType="pmc">PMC3723564</ArticleId><ArticleId IdType="pubmed">23935488</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y., Shimojima M., Tano Y., Miyamura T., Wakita T., Shimizu H. (2009). Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat. Med. 15:794. 10.1038/nm.1961</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Racaniello V. R. (2006). One hundred years of poliovirus pathogenesis. Virology 344 9&#x2013;16. 10.1016/j.virol.2005.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2005.09.015</ArticleId><ArticleId IdType="pubmed">16364730</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih C., Liao C.-C., Chang Y.-S., Wu S.-Y., Chang C.-S., Liou A.-T. (2018). Immunocompetent and immunodeficient mouse models for Enterovirus 71 pathogenesis and therapy. Viruses 10:674. 10.3390/v10120674</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10120674</ArticleId><ArticleId IdType="pmc">PMC6316343</ArticleId><ArticleId IdType="pubmed">30487421</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla D., Spear P. G. (2001). Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J. Clin. Invest. 108 503&#x2013;510. 10.1172/jci200113799</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci200113799</ArticleId><ArticleId IdType="pmc">PMC209412</ArticleId><ArticleId IdType="pubmed">11518721</ArticleId></ArticleIdList></Reference><Reference><Citation>Sin J., Mangale V., Thienphrapa W., Gottlieb R. A., Feuer R. (2015). Recent progress in understanding coxsackievirus replication, dissemination, and pathogenesis. Virology 484 288&#x2013;304. 10.1016/j.virol.2015.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.06.006</ArticleId><ArticleId IdType="pmc">PMC4567421</ArticleId><ArticleId IdType="pubmed">26142496</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C. W., Sam I. C., Lee V. S., Wong H. V., Chan Y. F. (2017). VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction. Virology 15 79&#x2013;87. 10.1016/j.virol.2016.11.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.11.009</ArticleId><ArticleId IdType="pubmed">27875780</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee H. K., Tan C. W., Yogarajah T., Lee M. H. P., Chai H. J., Hanapi N. A., et al. (2019). Electrostatic interactions at the five-fold axis alter heparin-binding phenotype and drive enterovirus A71 virulence in mice. PLoS Pathogens 15:e1007863. 10.1371/journal.ppat.1007863</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007863</ArticleId><ArticleId IdType="pmc">PMC6881073</ArticleId><ArticleId IdType="pubmed">31730673</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Sanden S. M., Sachs N., Koekkoek S. M., Koen G., Pajkrt D., Clevers H., Wolthers K. C. (2018). Enterovirus 71 infection of human airway organoids reveals VP1-145 as a viral infectivity determinant. Emerg. Microbes. Infect. 7 1&#x2013;9. 10.1038/s41426-018-0077-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41426-018-0077-2</ArticleId><ArticleId IdType="pmc">PMC5943241</ArticleId><ArticleId IdType="pubmed">29743570</ArticleId></ArticleIdList></Reference><Reference><Citation>Victorio C. B., Xu Y., Ng Q., Meng T., Chow V. T., Chua K. B. (2016). Cooperative effect of the VP1 amino acids 98E, 145A and 169F in the productive infection of mouse cell lines by enterovirus 71 (BS strain). Emerg. Microbes Infect. 5:e60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4932649</ArticleId><ArticleId IdType="pubmed">27329847</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen H. L., Si L. Y., Yuan X. J., Hao S. B., Gao F., Chu F. L., et al. (2013). Complete genome sequencing and analysis of six enterovirus 71 strains with different clinical phenotypes. Virol. J. 10:115. 10.1186/1743-422x-10-115</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422x-10-115</ArticleId><ArticleId IdType="pmc">PMC3669102</ArticleId><ArticleId IdType="pubmed">23577963</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W. H., Kuo T. C., Lin Y. T., Huang S. W., Liu H. F., Wang J., et al. (2013). Molecular epidemiology of enterovirus 71 infection in the central region of Taiwan from 2002 to 2012. PLoS One 8:e83711. 10.1371/journal.pone.0083711</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0083711</ArticleId><ArticleId IdType="pmc">PMC3877097</ArticleId><ArticleId IdType="pubmed">24391812</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W., Liao Q., Viboud C., Zhang J., Sun J., Wu J. T., et al. (2014). Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect. Dis. 14 308&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Yamashita Y., Li J., Hanagata N., Minowa T., Takemura T., et al. (2009). Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat. Med. 15 798&#x2013;801. 10.1038/nm.1992</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh M. T., Wang S. W., Yu C. K., Lin K. H., Lei H. Y., Su I. J., et al. (2011). A single nucleotide in stem loop II of 5&#x2019;-untranslated region contributes to virulence of enterovirus 71 in mice. PLoS One 6:e27082. 10.1371/journal.pone.0027082</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0027082</ArticleId><ArticleId IdType="pmc">PMC3206083</ArticleId><ArticleId IdType="pubmed">22069490</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng M., El Khatib N. F., Tu S., Ren P., Xu S., Zhu Q., et al. (2012). Seroepidemiology of Enterovirus 71 infection prior to the 2011 season in children in Shanghai. J. Clin. Virol. 53 285&#x2013;289. 10.1016/j.jcv.2011.12.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2011.12.025</ArticleId><ArticleId IdType="pubmed">22265829</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Yang P., Wang N., Zhang J., Li J., Guo H., et al. (2017). The binding of a monoclonal antibody to the apical region of SCARB2 blocks EV71 infection. Protein Cell 8 590&#x2013;600. 10.1007/s13238-017-0405-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-017-0405-7</ArticleId><ArticleId IdType="pmc">PMC5546930</ArticleId><ArticleId IdType="pubmed">28447294</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D., Zhao Y., Kotecha A., Fry E. E., Kelly J. T., Wang X., et al. (2019). Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2. Nat. Microb. 4 414&#x2013;419. 10.1038/s41564-018-0319-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0319-z</ArticleId><ArticleId IdType="pubmed">30531980</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>